From March 19 to 21, Besins Healthcare participated in the 16th European Society of Gynaecology Congress (ESG) held in Riga, Latvia.
With our dedicated booth, our teams connected with healthcare professionals from across Europe to discuss key topics in Women’s Health, including menopause, fertility, and pregnancy care.
Several scientific highlights emerged during the congress:
- A growing recognition of the benefit-risk profile of menopausal hormone therapy (MHT) in both sequential and continuous protocols.
- Increased awareness of the long-term benefits of initiating MHT early, including new perspectives on its use in women over 65.
- Evolving discussions around the role of micronised progesterone in the management of early miscarriage (EM) and preterm birth (PTB).
This event was a great opportunity to:
- Strengthen our position as one of the leaders in Women’s Health,
- Engage with the scientific community,
And showcase the expertise and collaboration of our global teams.
A warm thank you to all colleagues who contributed to Besins Healthcare’s strong presence and successful participation at ESG 2025.
Scroll down to view photos from our booth and team moments in Riga!
